Alpha DNA Investment Management’s Stifel SF Stock Holding History

Alpha DNA Investment Management’s Portfolio SF Stock Details SF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-38	Closed	-$1K	–	548
2021 Q1	$1K	Buy	+38	New	+$1.48K	﹤0.01%	646

Other funds holding SF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alpha DNA Investment Management's SF Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Stifel (SF) in Q2 2021, closing a stake of 38 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in SF in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 342 funds tracked by Wall St. Rank hold SF as of Q2 2021.

Alpha DNA Investment Management reported no remaining Stifel position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 38 Stifel shares in Q2 2021, an estimated $1K.
Alpha DNA Investment Management first reported a position in Stifel in Q1 2021 and held it in 1 quarter.
Alpha DNA Investment Management's Stifel position peaked at $1K in Q1 2021.
342 funds tracked by Wall St. Rank held Stifel as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.